H.R.____/S.____, Department of Defense Appropriations Bill, 2026, Title IV, all provisions related to biodefense preparedness. H.R.____/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.
2025 · 1st Quarter (Jan 1 - Mar 31)
ACURX PHARMACEUTICALS, INC.
Filed by INNOVATIVE FEDERAL STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- INNOVATIVE FEDERAL STRATEGIES, LLC
- Filing UUID
- e6e924c4-14f5-4ad1-a066-710fceaf4bb2
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.